EssilorLuxottica
EssilorLuxottica is a global leader in vision care, eyewear, and medical technology. Its mission is to help people see better and live more fully by meeting their changing vision needs, style preferences, and connection to the world around them. The company offers advanced lens technologies such as Varilux, Stellest, and Transitions, along with iconic eyewear brands like Ray-Ban, Oakley, and Supreme. It also manages leading retailers including Sunglass Hut, LensCrafters, Vision Express, and Apollo.
EssilorLuxottica invests heavily in research and innovation, developing everything from medical instruments for eye health to smart glasses that redefine how we use vision. With over 200,000 employees in 150 countries, the company also supports access to eye care through the OneSight EssilorLuxottica Foundation, which has helped nearly 1 billion people in underserved communities receive sustainable vision care.
EssilorLuxottica sponsored blogs.
EssilorLuxottica myopia management products
Myopia management products listed by Myopia Profile have been specifically designed for myopia control or myopia management in children, and have some form of regulatory approval or marking for this form of use. They also have randomized controlled trial research data supporting their efficacy, unless otherwise noted. It is up to the individual eye care practitioner to be aware of regulatory requirements for prescribing in their country of practice, and also be aware that not all products are available in all countries.Essilor® Stellest®
The Essilor® Stellest® lens with H.A.L.T.* Technology is considered a first-line option for slowing myopia in children. Clinical trials lasting two, three, and five years have shown strong results, with children benefiting from both clear distance vision and effective myopia control. The effect is even stronger when the lenses are worn every day for at least 12 hours. Stellest® lenses have been shown to work better than older designs such as progressive addition and bifocal lenses, making them one of the most effective myopia control spectacle lenses available.
*H.A.L.T. = Highly Aspherical Lenslet Target
Please note: Essilor® Stellest® lenses are not yet FDA approved and are not available in all countries, including the U.S.
Myopilux Max
Myopilux Max bifocal spectacle lenses provide both vision correction and some myopia control benefit. They are designed with prism in the addition zone to reduce disturbance to the binocular vision system. A three-year clinical trial showed a moderate effect in slowing myopia progression with this lens design. Where available, newer myopia control spectacle lenses such as Essilor® Stellest® may provide stronger results.